Standardising RNA profiling based biomarker application in cancer - the need for robust control of technical variables.

James P Stewart, Susan Richman, Tim Maughan, Mark Lawler, Philip D Dunne, Manuel Salto-Tellez,


Biochimica et biophysica acta, May 27, 2017


Histopathology-based staging of colorectal cancer (CRC) has utility in assessing the prognosis of patient subtypes, but as yet cannot accurately predict individual patient’s treatment response. Transcriptomics approaches, using array based or next generation sequencing (NGS) platforms, of formalin fixed paraffin embedded tissue can be harnessed to develop multi-gene biomarkers for predicting both prognosis and treatment response, leading to stratification of treatment. While transcriptomics can shape future biomarker development, currently

Copyright © 2017. Published by Elsevier B.V.


Pubmed Link: 28549623

DOI: 10.1016/j.bbcan.2017.05.005